Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rivard

Showing results (31-40 of 290) with videos related to

Pageof 29
Sort By:
Medical Physics|August 14, 2008
COMS eye plaque brachytherapy dosimetry simulations for 103Pd, 125I, and 131CsChristopher S Melhus, Mark J Rivard
Journal of Contemporary Brachytherapy|August 7, 2014
The evolution of computerized treatment planning for brachytherapy: American contributionsJesse N Aronowitz, Mark J Rivard
Journal of Contemporary Brachytherapy|July 24, 2013
The phylogeny of permanent prostate brachytherapyJesse N Aronowitz, Mark J Rivard
Journal of the American College of Radiology : JACR|March 4, 2008
Electronic brachytherapy: comparisons with external-beam and high-dose-rate 192Ir brachytherapyRandall W Holt, Mark J Rivard
Medical Physics|July 29, 2006
Approaches to calculating AAPM TG-43 brachytherapy dosimetry parameters for 137Cs, 125I, 192Ir, 103Pd, and 169Yb sourcesChristopher S Melhus, Mark J Rivard
Medical Physics|July 17, 2010
Enhancements to commissioning techniques and quality assurance of brachytherapy treatment planning systems that use model-based dose calculation algorithmsMark J Rivard, Luc Beaulieu, Firas Mourtada
Cancers|March 13, 2024
Current and Emerging Radiotherapy Options for Uveal MelanomaOleksii Semeniuk, Esther Yu, Mark J Rivard
American Journal of Physiology. Renal Physiology|April 9, 2001
Long-term adaptation of renal cells to hypertonicity: role of MAP kinases and Na-K-ATPaseJ M Capasso, C J Rivard, T Berl
Medical Physics|September 5, 2014
Independent dosimetric assessment of the model EP917 episcleral brachytherapy plaquePrakash Aryal, Janelle A Molloy, Mark J Rivard
American Journal of Physiology. Renal Physiology|June 29, 2006
Silencing and overexpression of the gamma-subunit of Na-K-ATPase directly affect survival of IMCD3 cells in response to hypertonic stressJuan M Capasso, Christopher J Rivard, Tomas Berl
Pageof 29

Showing results (31-40 of 290) with videos related to

Sort By:
Pageof 29
Medical Physics|August 14, 2008
COMS eye plaque brachytherapy dosimetry simulations for 103Pd, 125I, and 131CsChristopher S Melhus, Mark J Rivard
Journal of Contemporary Brachytherapy|August 7, 2014
The evolution of computerized treatment planning for brachytherapy: American contributionsJesse N Aronowitz, Mark J Rivard
Journal of Contemporary Brachytherapy|July 24, 2013
The phylogeny of permanent prostate brachytherapyJesse N Aronowitz, Mark J Rivard
Journal of the American College of Radiology : JACR|March 4, 2008
Electronic brachytherapy: comparisons with external-beam and high-dose-rate 192Ir brachytherapyRandall W Holt, Mark J Rivard
Medical Physics|July 29, 2006
Approaches to calculating AAPM TG-43 brachytherapy dosimetry parameters for 137Cs, 125I, 192Ir, 103Pd, and 169Yb sourcesChristopher S Melhus, Mark J Rivard
Medical Physics|July 17, 2010
Enhancements to commissioning techniques and quality assurance of brachytherapy treatment planning systems that use model-based dose calculation algorithmsMark J Rivard, Luc Beaulieu, Firas Mourtada
Cancers|March 13, 2024
Current and Emerging Radiotherapy Options for Uveal MelanomaOleksii Semeniuk, Esther Yu, Mark J Rivard
American Journal of Physiology. Renal Physiology|April 9, 2001
Long-term adaptation of renal cells to hypertonicity: role of MAP kinases and Na-K-ATPaseJ M Capasso, C J Rivard, T Berl
Medical Physics|September 5, 2014
Independent dosimetric assessment of the model EP917 episcleral brachytherapy plaquePrakash Aryal, Janelle A Molloy, Mark J Rivard
American Journal of Physiology. Renal Physiology|June 29, 2006
Silencing and overexpression of the gamma-subunit of Na-K-ATPase directly affect survival of IMCD3 cells in response to hypertonic stressJuan M Capasso, Christopher J Rivard, Tomas Berl
Pageof 29